| Dr Kathryn L Chubrilo, DO | |
|
501 E Hampden Ave, Englewood, CO 80113-2702 | |
| (303) 436-2727 | |
| Not Available |
| Full Name | Dr Kathryn L Chubrilo |
|---|---|
| Gender | Female |
| Speciality | Neurology |
| Experience | 9 Years |
| Location | 501 E Hampden Ave, Englewood, Colorado |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144616897 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084A2900X | Psychiatry & Neurology - Neurocritical Care | 036149249 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hca-healthone Dba Swedish Medical Center | Englewood, CO | Hospital |
| Lutheran Medical Center | Wheat ridge, CO | Hospital |
| Aurora South Hospital And Medical Center | Aurora, CO | Hospital |
| Rose Medical Center | Denver, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Carepoint Inpatient Blue Sky Neurology Pllc | 9436456118 | 33 |
News Archive
Titan Pharmaceuticals, Inc. today announced that the National Institutes of Health has awarded the company a grant under the Small Business Innovation Research program supporting the development of a long-term, non-fluctuating dopamine agonist treatment for Parkinson's disease. The first year award in the amount of $300,000 will be available to Titan starting August 1, 2010, and an additional $195,000 for the second year starting August 1, 2011 has been recommended subject to availability of funds and satisfactory progress of the project. The grant will be administered by the National Institute of Neurological Disorders and Stroke.
The World Health Organization on Thursday cautioned the Thai government on its decision to allow the country to produce a lower-cost version of Abbott Laboratories' antiretroviral drug Kaletra by granting a compulsory license for the drug, the Bangkok Post reports.
The more exercise taken by individuals aged 65 years and older, the less likely biomarkers indicative of cardiac injury and new-onset heart failure are to increase, show US study findings.
22nd Century Group, Inc., a company focused on smoking cessation and tobacco harm reduction products, announced today that the company licensed Hercules Pharmaceuticals LLC, its wholly-owned pharmaceutical subsidiary, exclusive worldwide rights to X-22.
A mouse model of endometriosis has been developed that produces endometriosis lesions similar to those found in humans, according to a report published in The American Journal of Pathology.
› Verified 3 days ago
| Entity Name | Carepoint Inpatient Blue Sky Neurology Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568833713 PECOS PAC ID: 9436456118 Enrollment ID: O20160323001467 |
News Archive
Titan Pharmaceuticals, Inc. today announced that the National Institutes of Health has awarded the company a grant under the Small Business Innovation Research program supporting the development of a long-term, non-fluctuating dopamine agonist treatment for Parkinson's disease. The first year award in the amount of $300,000 will be available to Titan starting August 1, 2010, and an additional $195,000 for the second year starting August 1, 2011 has been recommended subject to availability of funds and satisfactory progress of the project. The grant will be administered by the National Institute of Neurological Disorders and Stroke.
The World Health Organization on Thursday cautioned the Thai government on its decision to allow the country to produce a lower-cost version of Abbott Laboratories' antiretroviral drug Kaletra by granting a compulsory license for the drug, the Bangkok Post reports.
The more exercise taken by individuals aged 65 years and older, the less likely biomarkers indicative of cardiac injury and new-onset heart failure are to increase, show US study findings.
22nd Century Group, Inc., a company focused on smoking cessation and tobacco harm reduction products, announced today that the company licensed Hercules Pharmaceuticals LLC, its wholly-owned pharmaceutical subsidiary, exclusive worldwide rights to X-22.
A mouse model of endometriosis has been developed that produces endometriosis lesions similar to those found in humans, according to a report published in The American Journal of Pathology.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kathryn L Chubrilo, DO 5600 S Quebec St Ste 312a, Greenwood Village, CO 80111-2208 Ph: (303) 436-2727 | Dr Kathryn L Chubrilo, DO 501 E Hampden Ave, Englewood, CO 80113-2702 Ph: (303) 436-2727 |
News Archive
Titan Pharmaceuticals, Inc. today announced that the National Institutes of Health has awarded the company a grant under the Small Business Innovation Research program supporting the development of a long-term, non-fluctuating dopamine agonist treatment for Parkinson's disease. The first year award in the amount of $300,000 will be available to Titan starting August 1, 2010, and an additional $195,000 for the second year starting August 1, 2011 has been recommended subject to availability of funds and satisfactory progress of the project. The grant will be administered by the National Institute of Neurological Disorders and Stroke.
The World Health Organization on Thursday cautioned the Thai government on its decision to allow the country to produce a lower-cost version of Abbott Laboratories' antiretroviral drug Kaletra by granting a compulsory license for the drug, the Bangkok Post reports.
The more exercise taken by individuals aged 65 years and older, the less likely biomarkers indicative of cardiac injury and new-onset heart failure are to increase, show US study findings.
22nd Century Group, Inc., a company focused on smoking cessation and tobacco harm reduction products, announced today that the company licensed Hercules Pharmaceuticals LLC, its wholly-owned pharmaceutical subsidiary, exclusive worldwide rights to X-22.
A mouse model of endometriosis has been developed that produces endometriosis lesions similar to those found in humans, according to a report published in The American Journal of Pathology.
› Verified 3 days ago
Dr. Stephen Michael Allen, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 3601 S Clarkson St, Suite 540, Englewood, CO 80113 Phone: 303-741-0239 | |
Grace Wong, Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 6500 S Quebec St, Suite 300, Englewood, CO 80111 Phone: 303-320-5503 Fax: 303-220-9134 | |
Dr. Jeffrey C Wagner, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 499 E Hampden Ave, Suite 360, Englewood, CO 80113 Phone: 303-781-4485 Fax: 303-788-7666 | |
Khoi Duy Pham, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 501 E Hampden Ave, Englewood, CO 80113 Phone: 303-788-6911 Fax: 303-306-7753 | |
Oliver J Jeffery, MBCHB Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 499 E Hampden Ave Ste 360, Englewood, CO 80113 Phone: 303-781-4485 Fax: 720-274-0064 | |
Alan D Megibow, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 155 Inverness Dr W, Suite 110, Englewood, CO 80112 Phone: 303-999-2300 Fax: 303-889-4811 | |
Michael Makley, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3425 S Clarkson St, Englewood, CO 80113 Phone: 303-789-8220 Fax: 303-789-8470 |